Guarini Kathryn

Insider profile

Guarini Kathryn's trades of Regeneron Pharmaceuticals, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-30 2026-10-30 PrS Proposed sale
76,407
355.80
US$3,183,618
76,407 355.80 US$3,183,618
2026-09-03 2026-09-02 PlS Planned sale
9,564 -18.7%
398.71
US$1,735,925
9,564 -18.7% 398.71 US$1,735,925
2026-09-02 2026-09-02 PrS Proposed sale
59,092
397.23
US$4,590,008
59,092 397.23 US$4,590,008
2026-08-12 2026-08-10 PlS Planned sale
400 -39.9%
800.00
US$320,000
400 -39.9% 800.00 US$320,000
2026-08-10 2026-08-10 PrS Proposed sale
400
800.00
US$320,000
400 800.00 US$320,000